Data for: Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy

Main Author: Wang, Huijuan
Format: Dataset
Terbitan: Mendeley , 2019
Subjects:
Fig
Online Access: https:/data.mendeley.com/datasets/9g58y64x5d
Daftar Isi:
  • Supplemental figure. The effect of EGFR-TKIs in patients with uncommon EGFR mutations showed a similar PFS, but OS was lower than in advanced lung adenocarcinoma patients with common EGFR mutations.